Cancer Management in Man : Biological Response Modifiers, Chemotherapy, Antibiotics, Hyperthermia, Supporting Measures

This volume, the last in this series on cancer growth and Moreover, the current status of plant-derived vinca alka­ progression, is a companion volume to Volume IX and loids and non-alkaloid natural products is summarized. further explores established and novel approaches for the Advances in hyperthermia and additional approaches for therapy of patients with malignant neoplasms. The stra­ the therapy of malignancies are also presented. tegies reflected in these volumes are direct extrapolations The volume continues with chapters on bone marrow from the basic science of cancer biology, growth and pro­ transplantation as well as hematologic and nutritional sup­ gression described in earlier volumes of this series. Some port for the cancer patient. Blood pressure in the cancer approaches are directed towards the eradication or modifi­ patient, therapy for nausea and vomiting as well as pain are cation of the properties of heterogeneous malignant tumor discussed. The last chapter is devoted to the problems of the cells at various stages of tumor progression, while other terminally ill, including evaluations of the burden relatives approaches are directed towards modification of the host and friends of the cancer patient have to bear. antitumor defense systems, e. g. , enhancement of host anti­ It is clear that important advances in the basic science of tumor immune reactivity. This volume, the last in this series on cancer growth and Moreover, the current status of plant-derived vinca alkaƯ progression, is a companion volume to Volume IX and loids and non-alkaloid natural products is summarized. further explores established and novel approaches for the Advances in hyperthermia and additional approaches for therapy of patients with malignant neoplasms. The straƯ the therapy of malignancies are also presented. tegies reflected in these volumes are direct extrapolations The volume continues with chapters on bone marrow from the basic science of cancer biology, growth and proƯ transplantation as well as hematologic and nutritional supƯ gression described in earlier volumes of this series. Some port for the cancer patient. Blood pressure in the cancer approaches are directed towards the eradication or modifiƯ patient, therapy for nausea and vomiting as well as pain are cation of the properties of heterogeneous malignant tumor discussed. The last chapter is devoted to the problems of the cells at various stages of tumor progression, while other terminally ill, including evaluations of the burden relatives approaches are directed towards modification of the host and friends of the cancer patient have to bear. antitumor defense systems, e. g., enhancement of host antiƯ It is clear that important advances in the basic science of tumor immune reactivity Front Matter....Pages i-x Biological Response Modifiers....Pages 1-8 Antitumor Effects of Interferons....Pages 9-20 Transcatheter Management of Neoplams....Pages 21-34 Antifolates....Pages 35-53 Purine Antimetabolites....Pages 54-62 Alkylating Agents....Pages 63-84 Platinum Compounds....Pages 85-97 Nitrosoureas....Pages 98-112 Triazine and Hydrazine Derivatives....Pages 113-124 Anthracycline Antibiotics....Pages 125-130 Actinomycin....Pages 131-133 Other Antitumor Antibiotics....Pages 134-146 Plant Alkaloids: The Vinca Alkaloids....Pages 147-151 Non-Alkaloid Natural Products as Anticancer Agents....Pages 152-158 Hyperthermia....Pages 159-164 Current Advances in BMT for Cancer Treatment....Pages 165-179 Hematologic Support of the Patient with Malignancy....Pages 180-188 The Sphygmochron for Chronobiologic Blood Pressure and Heart Rate Assessment in Cancer Patients....Pages 189-195 Nutritional Support of Cancer Patients during Cancer Progression....Pages 196-203 Palliative Chemotherapy: Cancer Chemotherapy-Induced Nausea and Vomiting....Pages 204-206 Chronic Pain Management....Pages 207-215 Care for the Terminally Ill: Death and Dying....Pages 216-226 Back Matter....Pages 227-248